ImmuCell Reports Q3 Sales Up 46% to $8.0 Million
Preliminary, unaudited third-quarter sales were $8.0 million, up 46.0% year over year. Domestic sales rose 29.2% to $6.9 million; nine-month sales increased 27.8% to $25.6 million.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Preliminary, unaudited third-quarter sales were $8.0 million, up 46.0% year over year. Domestic sales rose 29.2% to $6.9 million; nine-month sales increased 27.8% to $25.6 million.